AlderMed™ announced today it has entered into a three-year exclusive distribution agreement with Gulmay Medical™, manufacturer of the Xstrahl-100 therapy system. AlderMed provides the first mobile service to bring low-dose superficial radiotherapy treatment directly to the point-of-care. Together they strive to bring skin cancer patients a non-surgical, painless and effect treatment for non-melanoma skin cancer at their dermatology and cosmetic surgery office.
Applying the AlderMed SRTeam service model, along with the proprietary mobile x-ray technology of the Xstrahl-100™ system, dermatologists can offer their patients more choices when treating basal cell and squamous cell carcinomas. Not only does AlderMed deliver the treatment, it brings added expertise to the dermatologist by providing its own staff of radiation therapists, including access to consultation with medical physicists and radiation oncologists. When compared to other treatment modalities and surgical options, the Xstrahl-100 delivers high cure rates, low recurrence rates, no scarring and the convenience of treatment at the doctor's office.
"We are privileged to work with the global leader in X-ray therapy devices," said Larry Findleton, president at AlderMed. "We believe our service improves the quality of care for the patient. At the same time, increasing the value of the dermatologist's practice, by bringing a very affordable, mobile non-surgical skin cancer treatment service to their office."
"We are very impressed with the AlderMed SRTeam approach," says Adrian Treverton, Sales Director of Xstrahl. "Including the oncologist, medical physicist and radiation therapist as part of the treatment approach shares our vision of effective delivery of superficial radiation therapy."
Xstrahl receives FDA 510 (k) clearance for marketing its Photoelectric Therapy System